Trifenagrel
Trifenagrel is an orally active platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].
Product Specifications
CAS Number
84203-09-8
UNSPSC
12352005
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/trifenagrel.html
Purity
99.35
Solubility
DMSO : 36 mg/mL (ultrasonic)
Smiles
CN(C)CCOC1=C(C=CC=C1)C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2
Molecular Formula
C25H25N3O
Molecular Weight
383.49
References & Citations
[1]Abrahams SL, et al. Trifenagrel: a chemically novel platelet aggregation inhibitor. J Pharmacol Exp Ther. 1989 May;249 (2) :359-65.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NRSN1 CRISPR All-in-one AAV vector set (with saCas9)(Rat)
Recombinant Lactococcus lactis subsp. lactis UPF0758 protein LL1007 (LL1007)
Recombinant Lactococcus lactis subsp. lactis UPF0758 protein LL1007 (LL1007)
Recombinant Lactococcus lactis subsp. lactis UPF0758 protein LL1007 (LL1007)